Proton pump inhibitors and Raynaud's phenomenon: is there a link?

被引：1

作者：

Khouri, Charles ^{[1
,2
,3
]}

Revol, Bruno ^{[1
,3
]}

Cracowski, Jean-Luc ^{[2
,3
]}

Roustit, Matthieu ^{[2
,3
]}

机构：

[1] Grenoble Alpes Univ Hosp, Pharmacovigilance Unit, Grenoble, France

[2] Grenoble Alpes Univ Hosp, Clin Pharmacol Dept, Grenoble, France

[3] Grenoble Alpes Univ, Lab HP2, Grenoble, France

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2018年 / 84卷 / 10期

关键词：

drug safety; proton pump inhibitors; Raynaud's phenomenon; ASYMMETRIC DIMETHYLARGININE; RISK-FACTOR;

D O I：

10.1111/bcp.13697

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：2443 / 2444

页数：2

共 10 条

[1]

Alexander SPH, 2017, BRIT J PHARMACOL, V174, pS272, DOI [10.1111/bph.13882, 10.1111/bph.13877]

[2]

European Medicines Agency EudraVigilance Expert Working Group, EMEA1064642006

[3] Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports [J].

Evans, SJW ;

Waller, PC ;

Davis, S .

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2001, 10 (06) :483-486

[4] Unexpected Effect of Proton Pump Inhibitors: Elevation of the Cardiovascular Risk Factor Asymmetric Dimethylarginine [J].

Ghebremariam, Yohannes T. ;

LePendu, Paea ;

Lee, Jerry C. ;

Erlanson, Daniel A. ;

Slaviero, Anna ;

Shah, Nigam H. ;

Leiper, James ;

Cooke, John P. .

CIRCULATION, 2013, 128 (08) :845-853

[5] The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY [J].

Harding, Simon D. ;

Sharman, Joanna L. ;

Faccenda, Elena ;

Southan, Chris ;

Pawson, Adam J. ;

Ireland, Sam ;

Gray, Alasdair J. G. ;

Bruce, Liam ;

Alexander, Stephen P. H. ;

Anderton, Stephen ;

Bryant, Clare ;

Davenport, Anthony P. ;

Doerig, Christian ;

Fabbro, Doriano ;

Levi-Schaffer, Francesca ;

Spedding, Michael ;

Davies, Jamie A. .

NUCLEIC ACIDS RESEARCH, 2018, 46 (D1) :D1091-D1106

[6] The pathogenesis, diagnosis and treatment of Raynaud phenomenon [J].

Herrick, Ariane L. .

NATURE REVIEWS RHEUMATOLOGY, 2012, 8 (08) :469-479

[7] Plasma asymmetric dimethylarginine predicts death and major adverse cardiovascular events in individuals referred for coronary angiography [J].

Lu, Tse-Min ;

Chung, Ming-Yi ;

Lin, Ming-Wei ;

Hsu, Chiao-Po ;

Lin, Shing-Jong .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 153 (02) :135-140

[8] Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population [J].

Shah, Nigam H. ;

LePendu, Paea ;

Bauer-Mehren, Anna ;

Ghebremariam, Yohannes T. ;

Iyer, Srinivasan V. ;

Marcus, Jake ;

Nead, Kevin T. ;

Cooke, John P. ;

Leeper, Nicholas J. .

PLOS ONE, 2015, 10 (06)

[9] Proton pump inhibitor use represents an independent risk factor for myocardial infarction [J].

Shih, Chia-Jen ;

Chen, Yung-Tai ;

Ou, Shuo-Ming ;

Li, Szu-Yuan ;

Chen, Tzeng-Ji ;

Wang, Shuu-Jiun .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 177 (01) :292-297

[10] Proton Pump Inhibitors Accelerate Endothelial Senescence [J].

Yepuri, Gautham ;

Sukhovershin, Roman ;

Nazari-Shafti, Timo Z. ;

Petrascheck, Michael ;

Ghebre, Yohannes T. ;

Cooke, John P. .

CIRCULATION RESEARCH, 2016, 118 (12) :E36-+

← 1 →